Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell

Gerda Kildisiute(Wellcome Sanger Institute), Waleed M. Kholosy(Princess Máxima Center), Matthew D. Young(Wellcome Sanger Institute), Kenny Roberts(Wellcome Sanger Institute), Rasa Elmentaite(Wellcome Sanger Institute), Sander R. van Hooff(Princess Máxima Center), Clarissa N. Pacyna(Wellcome Sanger Institute), Eleonora Khabirova(Wellcome Sanger Institute), Alice Piapi(Great Ormond Street Hospital), Christine Thevanesan(Great Ormond Street Hospital), Eva Bugallo-Blanco(Great Ormond Street Hospital), Christina Burke(Great Ormond Street Hospital), Lira Mamanova(Wellcome Sanger Institute), Kaylee M. Keller(Princess Máxima Center), Karin P.S. Langenberg(Princess Máxima Center), Philip Lijnzaad(Princess Máxima Center), Thanasis Margaritis(Princess Máxima Center), Frank C. P. Holstege(Princess Máxima Center), Michelle L. Tas(Princess Máxima Center), Marc H. W. A. Wijnen(Princess Máxima Center), Max M. van Noesel(Princess Máxima Center), Ignacio del Valle(Great Ormond Street Hospital), Giuseppe Barone(Great Ormond Street Hospital for Children NHS Foundation Trust), Reinier van der Linden(Hubrecht Institute for Developmental Biology and Stem Cell Research), Catriona Duncan(Great Ormond Street Hospital for Children NHS Foundation Trust), John Anderson(Great Ormond Street Hospital), John C. Achermann(Great Ormond Street Hospital), Muzlifah Haniffa(Wellcome Sanger Institute), Sarah A. Teichmann(Wellcome Sanger Institute), Dyanne Rampling(Great Ormond Street Hospital for Children NHS Foundation Trust), Neil J. Sebire(Great Ormond Street Hospital for Children NHS Foundation Trust), Xiaoling He(Wellcome/MRC Cambridge Stem Cell Institute), Ronald R. de Krijger(Heidelberg University), Roger A. Barker(Wellcome/MRC Cambridge Stem Cell Institute), Kerstin B. Meyer(Wellcome Sanger Institute), Omer Ali Bayraktar(Wellcome Sanger Institute), Karin Straathof(Great Ormond Street Hospital), Jan J. Molenaar(Princess Máxima Center), Sam Behjati(University of Cambridge)
Science Advances
February 5, 2021
Cited by 156Open Access
Full Text

Abstract

Neuroblastoma is a childhood cancer that resembles developmental stages of the neural crest. It is not established what developmental processes neuroblastoma cancer cells represent. Here, we sought to reveal the phenotype of neuroblastoma cancer cells by comparing cancer ( n = 19,723) with normal fetal adrenal single-cell transcriptomes ( n = 57,972). Our principal finding was that the neuroblastoma cancer cell resembled fetal sympathoblasts, but no other fetal adrenal cell type. The sympathoblastic state was a universal feature of neuroblastoma cells, transcending cell cluster diversity, individual patients, and clinical phenotypes. We substantiated our findings in 650 neuroblastoma bulk transcriptomes and by integrating canonical features of the neuroblastoma genome with transcriptional signals. Overall, our observations indicate that a pan-neuroblastoma cancer cell state exists, which may be attractive for novel immunotherapeutic and targeted avenues.


Related Papers

No related papers found

Powered by citation graph analysis